Cryosite Limited (ASX:CTE)
0.8000
0.00 (0.00%)
Aug 27, 2025, 10:15 AM AEST
Cryosite Revenue
In the fiscal year ending June 30, 2025, Cryosite had annual revenue of 14.12M AUD with 11.93% growth. Cryosite had revenue of 7.48M in the half year ending June 30, 2025, with 20.33% growth.
Revenue
14.12M
Revenue Growth
+11.93%
P/S Ratio
2.77
Revenue / Employee
564.64K
Employees
25
Market Cap
39.05M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2025 | 14.12M | 1.50M | 11.93% |
Jun 30, 2024 | 12.61M | 677.00K | 5.67% |
Jun 30, 2023 | 11.94M | 178.00K | 1.51% |
Jun 30, 2022 | 11.76M | 1.73M | 17.29% |
Jun 30, 2021 | 10.02M | 1.10M | 12.38% |
Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 23.73B |
Pro Medicus | 212.98M |
Cochlear | 2.34B |
Sonic Healthcare | 9.65B |
Ramsay Health Care | 17.85B |
Telix Pharmaceuticals | 1.01B |
Ansell | 3.06B |
Mesoblast | 26.23M |